Exome Asset Management LLC Alvotech Transaction History
Exome Asset Management LLC
- $133 Billion
- Q4 2024
A detailed history of Exome Asset Management LLC transactions in Alvotech stock. As of the latest transaction made, Exome Asset Management LLC holds 90,100 shares of ALVO stock, worth $1.15 Million. This represents 0.9% of its overall portfolio holdings.
Number of Shares
90,100
Previous 90,100
-0.0%
Holding current value
$1.15 Million
Previous $1.07 Billion
11.18%
% of portfolio
0.9%
Previous 0.72%
Shares
2 transactions
Others Institutions Holding ALVO
# of Institutions
45Shares Held
14.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA3.2MShares$40.9 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$34.6 Million5.53% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.93MShares$24.6 Million0.65% of portfolio
-
Morgan Stanley New York, NY1.48MShares$18.9 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$16.9 Million7.91% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $3.18B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...